Hepatitis E Vaccines Market Forecast to USD 247.5 million by 2034, Growing 20.62% a Year
Market reaches USD 247.5 million by 2034, up from USD 45.6 million in 2025, at a 20.62% CAGR.
Market findings and research announcements from the CDI research team. Showing 73–84 of 1716.
Market reaches USD 247.5 million by 2034, up from USD 45.6 million in 2025, at a 20.62% CAGR.
Market reaches USD 538 million by 2034, up from USD 285 million in 2025, at a 7.34% CAGR.
From USD 6.25 billion in 2025 to USD 16.36 billion in 2034, a 11.23% compound annual rate.
Market reaches USD 64.2 billion by 2034, up from USD 24.5 billion in 2025, at a 11.07% CAGR.
From USD 4.2 billion in 2025 to USD 14.21 billion in 2034, a 14.5% compound annual rate.
Market reaches USD 102.7 billion by 2034, up from USD 68.5 billion in 2025, at a 4.61% CAGR.
From USD 1.65 billion in 2025 to USD 5.56 billion in 2034, a 14.6% compound annual rate.
Market reaches USD 6.42 billion by 2034, up from USD 3.24 billion in 2025, at a 8.04% CAGR.
From USD 4.3 billion in 2025 to USD 30.5 billion in 2034, a 23.99% compound annual rate.
Market reaches USD 3.42 billion by 2034, up from USD 1.85 billion in 2025, at a 7.2% CAGR.
Market reaches USD 13.1 billion by 2034, up from USD 8.7 billion in 2025, at a 4.52% CAGR.
From USD 4.9 billion in 2025 to USD 15.25 billion in 2034, a 13.21% compound annual rate.
For comment on a published finding, or to request the full study behind a release, contact the research team.